Patents by Inventor Lindsey N. Shaw

Lindsey N. Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DENDRILLA MEMBRANOSA COMPOUNDS, DERIVATIVES THEREOF, AND USES THEREOF
    Publication number: 20230165830
    Abstract: Described herein are Dendrilla membranosa compounds and derivatives thereof. Also described herein are formulations that can contain an amount of one or more Dendrilla membranosa compounds or derivatives thereof and a carrier. Also described herein are methods of administering one or more Dendrilla membranosa compound and/or derivative thereof or a formulation thereof to a subject in need thereof.
    Type: Application
    Filed: January 9, 2023
    Publication date: June 1, 2023
    Inventors: Bill J. Baker, Lindsey N. Shaw, Andrew Jason Shilling, Alexandre Jean Bory, Jessie Allen (Adams), Charles Dunkle Amsler, JR., James Bruce McClintock
  • compounds, derivatives thereof, and uses thereof
    Patent number: 11547691
    Abstract: Described herein are Dendrilla membranosa compounds and derivatives thereof. Also described herein are formulations that can contain an amount of one or more Dendrilla membranosa compounds or derivatives thereof and a carrier. Also described herein are methods of administering one or more Dendrilla membranosa compound and/or derivative thereof or a formulation thereof to a subject in need thereof.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: January 10, 2023
    Assignees: UNIVERSITY OF SOUTH FLORIDA, THE UAB RESEARCH FOUNDATION
    Inventors: Bill J. Baker, Lindsey N. Shaw, Andrew Jason Shilling, Alexandre Jean Bory, Jessie Allen (Adams), Charles Dunkle Amsler, Jr., James Bruce McClintock
  • MRSA biofilm inhibition
    Patent number: 11213507
    Abstract: Provided is a darwinolide compound having a previously undescribed carbon skeleton and the crystalline form thereof. Also provided are processes of isolating darwinolide, compositions comprising darwinolide, and methods of treating infection, such as a methicillin-resistant Staphylococcus aureus biofilm infection.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: January 4, 2022
    Assignees: UNIVERSITY OF SOUTH FLORIDA, UAB RESEARCH FOUNDATION
    Inventors: Bill J. Baker, Lindsey N. Shaw, James Bruce McClintock, Charles D. Amsler, Jacqueline Lee Fries, Witowski G. Christopher, Renee M. Fleeman
  • MRSA BIOFILM INHIBITION
    Publication number: 20210205266
    Abstract: Provided is a darwinolide compound having a previously undescribed carbon skeleton and the crystalline form thereof. Also provided are processes of isolating darwinolide, compositions comprising darwinolide, and methods of treating infection, such as a methicillin-resistant Staphylococcus aureus biofilm infection.
    Type: Application
    Filed: April 17, 2017
    Publication date: July 8, 2021
    Inventors: Bill J. Baker, Lindsey N. Shaw, James Bruce McClintock, Charles D. Amsler, Jacqueline Lee Fries, Witowski G. Christopher, Renee M. Fleeman
  • NN N-disubstituted quinazoline-2,4-diamines and uses thereof
    Patent number: 10323007
    Abstract: Described herein are quinazoline-based compounds and formulations thereof. In some embodiments, the compounds and/or formulations thereof can be effective to inhibit and/or kill A. baumannii. Also described herein are methods of treating a subject in need thereof by administering to the subject in need thereof a quinazoline-based compound and/or formulation thereof to the subject in need thereof.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: June 18, 2019
    Assignee: University of South Florida
    Inventors: Roman Manetsch, Kurt S. Van Horn, Whittney Burda, Lindsey N. Shaw, Renee Fleeman, Megan Barber, David Lawrence Flanigan